Position in CELC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$50,132,684
+$32,031,371 QoQ
Shares Held
439,221
+142.0% QoQ
Ownership
0.901%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 78.9959951823797.ToString("F0")%
Shared 0.ToString("F0")%
None 21.004004817620288.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LORD, ABBETT & CO. LLC holds $1,298,705,726 across 29 Biotechnology names. CELC ranks #11 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,812,938 | $148,298,091 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
242,726 | $127,059,779 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,181,270 | $122,447,082 | |
| 4 | ARGX |
Argenx SE
|
152,083 | $111,058,610 | |
| 5 | ABVX |
Abivax S.A.
|
854,920 | $95,195,342 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
1,023,341 | $75,993,302 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
166,509 | $74,352,928 | |
| 8 | INSM |
INSMED Inc
|
397,261 | $64,960,118 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,132,684 | 439,221 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $18,101,313 | 181,485 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,244,975 | 247,874 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||